ArticleMolecular medicine reports2021

LY‑294002 enhances the chemosensitivity of liver cancer to oxaliplatin by blocking the PI3K/AKT/HIF‑1α pathway.

Ruyue Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.